Metabolic Syndrome
Conditions
Keywords
Prediabetic State, Hypertension, Enlarged Waist Elevated Triglycerides, HDL Cholesterol, Low Serum
Brief summary
Approximately 24% of the US adult population meet criteria for metabolic syndrome (MetS), diagnosed by a combination of abdominal obesity, elevated blood pressure, high triglyceride and low HDL-cholesterol level, and pre-diabetes. MetS quintuples the risk of diabetes, and doubles the risk of cardiovascular disease (CVD), particularly heart failure. Lifestyle modification is the initial step of treatment, but few studies have demonstrated early and sustained efficacy in remission of MetS. Our preliminary studies of a lifestyle change program for patients with MetS included a 1-year of development of an intervention by an interdisciplinary team of experts in medicine and the behavioral sciences. The investigators then tested the efficacy of the intervention in a treatment-only, proof-of-concept study. The investigators achieved our goal of 50% MetS remission after 2 years, in a sample of 26 patients. This study is the second step of a research program testing an innovative bio-behavioral intervention aimed at remitting MetS through lifestyle intervention, by focusing on eating patterns, daily activity, and stress management. The overarching objective of this research program is to determine the efficacy of the ELM lifestyle intervention to achieve remission of MetS. This purpose of the current study is to prepare for a large, randomized, clinical trial by conducting a smaller clinical trial that examines the acceptability of the ELM intervention (ELM Group) as compared to two other intervention arms (ELM Classes, ELM Individual).
Detailed description
The 3ELM (Eat, Love, Move) study recruits 48 patients with MetS, and provides a 6-month intervention that aims to remit MetS by promoting the long-term adoption of healthier behaviors (diet, physical activity, stress reduction). Participants in 3ELM are randomly assigned to one of the study arms (ELM Groups, ELM Classes, ELM Individual); all of which receive some type of intervention in either group, class, or individual formats. The primary aim of this project is to pilot test the acceptability of each of the study arms and the outcome measures. The study also includes outcome assessments at 3 time points: at the start of the study, and at 3, and 6 months post baseline. All study participants will receive medical care (including metabolic syndrome care) from their regular medical doctors. Study staff will track participants' use of health care and wellness services during the study after obtaining participant permission to collect this data.
Interventions
BEHAVIORALELM Group
ELM participants are trained to portion their meals according to the Perfect Plate method, a modified version of the USDA's ChooseMyPlate.gov. The stress management focuses on mindful living, cognitive restructuring; the enhancement of positive emotions. The physical activity component focuses on reduction of sedentary activity (by increasing daily step counts) and moderate-to-vigorous physical activity.
OTHERELM Classes
ELM classes will be administered through Rush Generations program and focus on health education.
OTHERELM Individual
ELM Individual arm participants will receive education materials on metabolic syndrome and diet, exercise, stress reduction recommendations. The participants will be recommended to follow these guidelines and discuss/seek support from their health care provider (visits at baseline, 3 and 6 months will be recommended.
Sponsors
National Heart, Lung, and Blood Institute (NHLBI)
Rush University Medical Center
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 72 Years
Healthy volunteers
No
Inclusion criteria
* Men and women age 18-72 years (children and the elderly need age-specific lifestyle tailoring). * Able to walk 2 blocks (the patients should be able to engage in moderate intensity exercise). * Have preference for making lifestyle changes to treat MetS. * Able to participate in a lifestyle intervention for 6 months. * Meet at least 3 Metabolic syndrome criteria: abdominal obesity (waist girth \>102♂/88♀ cm), high blood pressure (≥130/85 mm Hg or treatment), triglyceridemia (≥150 mg/dL or fibrate therapy), low HDL-cholesterol (\<40♂/50♀ mg/dL or niacin therapy) or fasting glucose ≥100 mg/dL (or pre-diabetes).
Exclusion criteria
* Substance abuse within the past 12 months: alcohol use, current daily smokers (self-report); and illicit drug use. * Weight loss, exceeding 10% of initial weight, in the past 6 months or current use of medications for weight loss, bowel resection surgery, bariatric surgery, eating disorder. * Other medical or behavioral limitations judged to interfere with study participation or the ability to follow study procedures (eg, scheduled surgery, travel plans or scheduling difficulties that do not permit full participation), limited English language, cognitive impairment, pregnancy, or psychiatric comorbidities (such as severe major depression, or psychotic disorders).
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| metabolic syndrome remission, defined as <3 of the 5 standard diagnostic criteria. | 6-month change | metabolic syndrome remission will be assessed by measurement of waist girth, blood pressure, fasting serum lipid and glucose levels, and the number of medications to treat blood pressure. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Accelerometry | At baseline and 6 months | Accelerometry (Actigraph) is the gold standard objective method for daily activity data collection. Standard methods for equipment programming and data reduction, supplemented by activity and sleep log will be used to calculate minutes/week of moderate/vigorous activity, sedentary activity, sleep, and accelerometer step counts. |
| International Physical Activity Questionnaire (IPAQ) | At baseline and 6 months | Measures engagement in physical activity |
| Perceived Stress Scale | At baseline, 3, and 6 months | a 10-item questionnaire that measures stress |
| Weight | At baseline, 3, and 6 months | Weight will be measured using stationary scale per standardized protocol. |
| Nutrition intake | Baseline, and 6 months | Healthy Eating Index (HEI-2010) will be computed using data from 24-h dietary recalls, conducted on nonconsecutive days, including one weekend day, using the Nutrition Data System for Research (NDSR).128 The HEI-2010 is a quantifiable method of assessing the adherence to Dietary Guidelines for Americans. |
| Credibility and expectancies questionnaire (CEQ) | At baseline, 3, and 6 months | A 4-item questionnaire measures participants acceptability ratings - specifically whether they think the treatments are credible and if they think they will help them with their health goals. |
| Vitality Index | At baseline, 3, and 6 months | will be tracked using a 4 item subscale of Medical Outcomes Study (MOS) 36-Item Short Form Health survey that measures perceived energy and fatigue within the last 30 days. |
| Continuous metabolic syndrome score | At baseline, 3, and 6 months | calculated as a sum of z-scores of the individual 5 MetS components using reported methodology from other clinical trials. This MetS research tool has methodological advantage accounting for severity of MetS. |
| A1c | At baseline and 6 months | A plasma sample will be collected to measure HbA1c. |
Other
| Measure | Time frame | Description |
|---|---|---|
| General Questionnaire | At baseline, updated at 3, and 6 months | Measures basic sociodemographic characteristics. |
| Weight history and experiences with wellness/weight management programs | At baseline, and updated at 3 and 6 months | Captures weight fluctuations and participation in commercial or health care based wellness or weight loss programs |
| Treatment modality preferences and willingness | At baseline and 6 months | Captures participant preferences for lifestyle, medication, and surgical treatment modalities. |
| Medication questionnaire | At baseline, 3, and 6 months | The list of medications with dose and frequency of administration will be collected using a standardized questionnaire. |
| Time horizon | At baseline and 6 months | Assesses executive function |
| Patient Reported Outcomes Measurement Information System (PROMIS) Cognition questionnaire | At baseline and 6 months | measures cognitive/executive function. |
| Perceived lifestyle change for physical activity and diet | At 3 and 6 months | Captures participant's self-assessment of effort-related to lifestyle changes. |
| Beliefs about medications | At baseline | Captures participant's beliefs about the usefulness and safety of medications. |
| Brief COPE | At baseline, and 6 months | measures coping of stressors |
| Daily Hassles Questionnaire | At baseline, 3, and 6 months | measures primary and secondary appraisal of stressors. |
| Three Factor Eating Questionnaire (TFEQ) | At baseline, and 6 months | Measures disordered eating patterns. |
| Patient Health Questionnaire (PHQ-9) | At baseline, 3, and 6 months | Measures depressive symptoms |
| Treatment Self-Regulation Questionnaire (TSRQ for eating and physical activity) | At baseline, 3, and 6 months | Measures self-regulation abilities for eating and physical activity |
| Work Productivity and Activity Impairment Questionnaire | At baseline, 3, and 6 months | measures lost productivity in the form of absenteeism and presenteeism. |
| Use of wellness, health, and preventive services | At baseline, 3, and 6 months | Wil be used for cost analysis. |
| Perceived environment (food and exercise) | At baseline | measures the built and food environment |
| Global health scale | At baseline, 3, and 6 months | Self-assessment of overall health. |
Countries
United States
Outcome results
None listed